ACM
DGX icon

Anfield Capital Management’s Quest Diagnostics DGX Stock Holding History

Anfield Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.84K Hold
40
– – ﹤0.01% 466
2025
Q4 		$6.94K Hold
40
– – ﹤0.01% 368
2025
Q3 		$7.62K Hold
40
– – ﹤0.01% 359
2025
Q2 		$7.18K Hold
40
– – ﹤0.01% 337
2025
Q1 		$6.77K Hold
40
– – ﹤0.01% 292
2024
Q4 		$6.03K Hold
40
– – ﹤0.01% 297
2024
Q3 		$6.21K Hold
40
– – ﹤0.01% 291
2024
Q2 		$5.47K Buy
+40
New +$5.48K ﹤0.01% 254
2022
Q1 		– Sell
-212
Closed -$37K – 106
2021
Q4 		$37K Buy
212
+194
+1,078% +$29.5K 0.01% 86
2021
Q3 		$3K Buy
+18
New +$2.63K ﹤0.01% 101

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Anfield Capital Management's DGX Position: Q1 2026 in Review

Anfield Capital Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 40 shares worth $7.84K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Anfield Capital Management first reported a position in DGX in Q3 2021 and has held it in 10 quarters since. The position peaked at $37K in Q4 2021. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Anfield Capital Management held 40 shares of Quest Diagnostics worth $7.84K as of Q1 2026.
  • Anfield Capital Management left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #466 holding.
  • Anfield Capital Management first reported a position in Quest Diagnostics in Q3 2021 and has held it in 10 quarters since.
  • Anfield Capital Management's Quest Diagnostics position peaked at $37K in Q4 2021.
  • 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.